YDES
YD BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
YDES Profile
Yd Bio Limited
A biopharmaceutical company specializing in blood based cancer detection
Biological Technology
02/06/2024
08/29/2025
NASDAQ Stock Exchange
4
12-31
--
Common stock
12F., No. 3, Xingnan St., Nangang Dist., Taipei City 115001, Taiwan
--
YD Bio Limited was incorporated in the Cayman Islands on February 6, 2024. They are a biopharmaceutical company that focuses on blood-based cancer detection, develops stem cell and exosome-based therapies, has the potential to transform the treatment of broad-spectrum diseases with high unmet medical needs, and serves as a trusted supplier of clinical laboratory drugs for pharmaceutical companies. Their business model focuses on developing partnerships with biopharmaceutical companies to turn innovative technologies into commercially viable drugs and cancer detection.
